Zouboulis, C.C.; Hou, X.; von Waldthausen, H.; Zouboulis, K.C.; Hossini, A.M.
HS 3D-SeboSkin Model Enables the Preclinical Exploration of Therapeutic Candidates for Hidradenitis Suppurativa/Acne Inversa. Pharmaceutics 2023, 15, 619.
https://doi.org/10.3390/pharmaceutics15020619
AMA Style
Zouboulis CC, Hou X, von Waldthausen H, Zouboulis KC, Hossini AM.
HS 3D-SeboSkin Model Enables the Preclinical Exploration of Therapeutic Candidates for Hidradenitis Suppurativa/Acne Inversa. Pharmaceutics. 2023; 15(2):619.
https://doi.org/10.3390/pharmaceutics15020619
Chicago/Turabian Style
Zouboulis, Christos C., Xiaoxiao Hou, Henriette von Waldthausen, Konstantin C. Zouboulis, and Amir M. Hossini.
2023. "HS 3D-SeboSkin Model Enables the Preclinical Exploration of Therapeutic Candidates for Hidradenitis Suppurativa/Acne Inversa" Pharmaceutics 15, no. 2: 619.
https://doi.org/10.3390/pharmaceutics15020619
APA Style
Zouboulis, C. C., Hou, X., von Waldthausen, H., Zouboulis, K. C., & Hossini, A. M.
(2023). HS 3D-SeboSkin Model Enables the Preclinical Exploration of Therapeutic Candidates for Hidradenitis Suppurativa/Acne Inversa. Pharmaceutics, 15(2), 619.
https://doi.org/10.3390/pharmaceutics15020619